ราคา BIO

BIO Protocol is a decentralized science (DeSci) project that accelerates biotechnology innovation. It enables communities of patients, scientists, and biotech professionals to collectively fund and own biotech projects and intellectual property.

The platform operates through BioDAOs—decentralized autonomous organizations (DAOs) focused on specific scientific areas. As a participant, you can engage in governance, funding, and liquidity management within these BioDAOs.

BIO Protocol's native token, BIO, powers this ecosystem. Holding BIO allows you to vote on new BioDAOs, access early investment opportunities, and participate in governance decisions.

By joining BIO Protocol, you contribute to democratizing biotech funding and advancing scientific research through decentralized means.

BIO Protocol is a decentralized platform that accelerates biotech innovation by connecting scientists, patients, and investors. It enables the creation of BioDAOs—decentralized autonomous organizations focused on specific scientific areas. Through these BioDAOs, communities can collectively fund, develop, and own biotech projects and intellectual property (IP). 

By leveraging blockchain technology, BIO Protocol democratizes biotech development, making it more inclusive and efficient. It provides a financial layer for decentralized science, facilitating the creation of BioDAOs and enabling participation in their governance, giving holders exposure to the DeSci economy.

BIO Protocol (BIO) is a decentralized platform that accelerates biotechnology by enabling global communities to collectively fund, build, and own tokenized biotech projects and intellectual property.

The project was initiated in July 2021 with the launch of VitaDAO, focusing on longevity research. Key milestones include:

> August 2021: First on-chain science funding in partnership with the University of Copenhagen.

> December 2022: Pfizer Ventures backed VitaDAO in a $4.1 million round.

> June 2023: Launch of the first IP-Token from Newcastle University.

> November 2023: Aggregate market cap of BioDAO tokens surpassed $200 million.

> December 2023: HairDAO became the first DAO to file a scientific patent.

> November 2024: Binance Labs made its first DeSci investment in BIO Protocol.

> December 2024: BIO Genesis raised over $33 million.

> Q1 2025: BIO Protocol Launchpad is scheduled to go live, along with the introduction of BIO Research Agents. 

BIO Protocol's roadmap includes launching new BioDAOs, going live with the BIO Protocol Launchpad in Q1 2025, and introducing BIO Research Agents in 2025.

The BIO token serves multiple purposes within the ecosystem, including:

1. Curation: You can stake BIO tokens to vote on which new BioDAOs (decentralized autonomous organizations focused on specific areas of scientific research) should join the ecosystem. This process ensures that only high-quality projects align with the network's goals.

2. Funding: By holding BIO tokens, you gain access to early funding rounds for BioDAOs, allowing you to support innovative science from the beginning.

3. Liquidity Management: BIO tokens are used to provide liquidity for BioDAO tokens, ensuring stable and efficient markets within the ecosystem.

4. Governance: As a BIO token holder, you can participate in governance decisions across multiple BioDAOs, influencing the direction of various biotech projects.

5. Access and Discounts: Holding BIO tokens may grant you priority access to BioDAO token sales, IP-token sales, and discounts on BioDAO health products and services.

One practical use case is trading BIO Protocol tokens on cryptocurrency exchanges. For instance, KuCoin has launched BIO Protocol in Pre-Market Trading, allowing users to trade BIO ahead of its official launch on the Spot market.

The total supply of BIO Protocol is 3,320,000,000 BIO tokens at Genesis. The maximum suppy remains uncapped; future supply will depend on governance decisions. Additional BIO tokens can be minted for protocol or network growth by deploying new token contracts.

The BIO token distribution is as follows: 

> Community: 56% of total supply (1,859,200,000 BIO). Includes Community Auction, Community Airdrop, and Ecosystem Incentives.

> Community Auction: 20% of total supply (664,000,000 BIO). 50% liquid at launch, remaining 50% vests linearly over 1 year. Tokens allocated for initial token swaps during Genesis Auction rounds.

> Community Airdrop: 6% of total supply (199,200,000 BIO). 1-year cliff, followed by a 6-year vesting period. Distributed to BioDAO token holders and early supporters.

> Ecosystem Incentives: 25% of total supply (830,000,000 BIO). No vesting period. Reserved for ecosystem development, such as curation, investment rewards, and liquidity provisioning for bioDAOs.

> Molecule Ecosystem Fund: 5% of total supply (166,000,000 BIO). 4-year vesting period. Supports research and development initiatives, focusing on IP tokenization and AI research.

> Molecule: 5% of total supply (166,000,000 BIO). 4-year vesting period. Allocation for governance over IP, branding, and ecosystem stewardship by the Bio.xyz Association.

> Investors: 13.6% of total supply (451,520,000 BIO). 1-year cliff, followed by a 4-year vesting period. Reserved for strategic investors participating in the seed round.

> Core Contributors: 21.2% of total supply (703,840,000 BIO). 1-year cliff, followed by a 6-year vesting period. Allocated to the BIO team working on DAO incubation and development.

> Advisors: 4.2% of total supply (139,440,000 BIO). 1-year cliff, followed by a 6-year vesting period. Reserved for advisors with expertise in biotech, IP tokenization, and protocol development.